| Financial Year |
March 31 2023 |
| Monetary Funds |
20,194,784,507.94 |
| Held-for-trading Financial Assets |
3,214.40 |
| Notes Receivable |
860,881,025.35 |
| Accounts Receivable |
3,391,701,873.33 |
| Advances to Suppliers |
385,199,660.71 |
| Other Receivables |
401,477,250.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,575,374,565.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
647,329,225.46 |
| Total Current Assets |
30,262,713,325.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
27,000,000.00 |
| Long-term Equity Investment |
3,780,975,949.18 |
| Investment Properties |
209,395,056.04 |
| Fixed Assetes |
37,052,305,079.14 |
| Under-construction Projects |
3,285,734,328.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,540,911,015.02 |
| R&D expenses |
16,814,408.30 |
| Goodwill |
766,259,626.96 |
| Long-Term Deferred and Prepaid Expenses |
76,984,768.03 |
| Deferred Income Tax Assets |
556,846,729.51 |
| Other Non-Current Assets |
113,337,284.52 |
| Sub-Total of Non-Current Assets |
68,174,814,068.59 |
| Total Assets |
98,437,527,394.22 |
| Short-Term Loans |
1,827,086,388.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,861,583,818.01 |
| Accounts Payable |
12,156,310,627.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,273,621,794.96 |
| Taxes Payable |
2,149,350,676.76 |
| Interest Payable |
-- |
| Dividend Payable |
167,947,576.99 |
| Other payables |
2,292,630,615.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,869,893,704.03 |
| Other Current Liabilities |
509,631,517.42 |
| Sub-Total of Current Liabilities |
28,866,117,303.61 |
| Long-term Loans |
6,366,263,001.43 |
| Bonds Payable |
1,999,021,432.97 |
| Long-Term Accounts Payable |
11,622,229,745.03 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,248,749,458.54 |
| Deferred Income Tax Liabilities |
268,944,962.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,004,967,156.69 |
| Total Liabilities |
51,871,084,460.30 |
| Paid-In Capital(Or Share Stock) |
5,202,963,128.00 |
| Capital Surplus |
2,647,815,001.63 |
| Surplus Reserve |
734,614,218.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
25,778,774,001.17 |
| Minority Stockholder's Interest |
10,739,032,842.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
35,827,410,091.74 |
| Owner's Equity（Stockholder's Equity） |
46,566,442,933.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
98,437,527,394.22 |
